187 related articles for article (PubMed ID: 14999933)
1. [The strategy of treatment for malignant lymphoma: conventional-dose chemotherapy versus high-dose therapy followed by hematopoietic stem cell transplantation].
Watanabe T
Rinsho Ketsueki; 2004 Jan; 45(1):39-47. PubMed ID: 14999933
[No Abstract] [Full Text] [Related]
2. [Hematopoietic stem cell transplantation for malignant lymphoma].
Asaoku H
Nihon Rinsho; 2000 Mar; 58(3):704-8. PubMed ID: 10741150
[TBL] [Abstract][Full Text] [Related]
3. Tandem transplantation in lymphoma.
Papadopoulos KP; Noguera-Irizarry W; Hesdorffer CS
Bone Marrow Transplant; 2001 Sep; 28(6):529-35. PubMed ID: 11607764
[TBL] [Abstract][Full Text] [Related]
4. [High-dose chemotherapy for treatment of breast cancers].
Tokuda Y
Nihon Rinsho; 2000 Apr; 58 Suppl():292-7. PubMed ID: 11026009
[No Abstract] [Full Text] [Related]
5. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
6. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
[TBL] [Abstract][Full Text] [Related]
7. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Villanueva ML; Vose JM
Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
9. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
10. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer].
Viens P; Maraninchi D
Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355
[No Abstract] [Full Text] [Related]
11. Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.
Phillips GL; Abboud CN; Bernstein SH; Friedberg JW; Ifthikharuddin JJ; Lancet JE; Liesveld JL; Spreng E; Johnson V; Chapman M; Vesole DH
Semin Oncol; 2004 Dec; 31(6 Suppl 18):59-61. PubMed ID: 15726525
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
[TBL] [Abstract][Full Text] [Related]
13. Impact of high-dose chemotherapy with autologous hematopoietic stem cell transplantation on small-cell lung cancer.
Wang J; Zhan P; Ouyang J; Chen B; Zhou R; Yang Y
Lung Cancer; 2009 Jul; 65(1):126-7. PubMed ID: 19394108
[No Abstract] [Full Text] [Related]
14. Stem cell transplantation in Hodgkin lymphoma.
Murphy F; Sirohi B; Cunningham D
Expert Rev Anticancer Ther; 2007 Mar; 7(3):297-306. PubMed ID: 17338650
[TBL] [Abstract][Full Text] [Related]
15. [High dose chemotherapy with autologous peripheral blood stem cell transplantation in lung cancer].
Kiura K; Harada M
Nihon Rinsho; 2002 May; 60 Suppl 5():463-8. PubMed ID: 12101716
[No Abstract] [Full Text] [Related]
16. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem cell transplantation in lymphoma.
Schmitz N; Buske C; Gisselbrecht C
Semin Hematol; 2007 Oct; 44(4):234-45. PubMed ID: 17961722
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.
Vogl DT; Stadtmauer EA
Bone Marrow Transplant; 2006 Jun; 37(11):985-7. PubMed ID: 16708060
[No Abstract] [Full Text] [Related]
19. Treatment of mantle cell lymphoma: current approach and future directions.
Brody J; Advani R
Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
Zander AR; Kröger N; Schmoor C; Krüger W; Möbus V; Frickhofen N; Metzner B; Schultze W; Berdel WE; Koenigsmann M; Thiel E; Wandt H; Possinger K; Trümper L; Kreienberg R; Carstensen M; Schmidt EH; Jänicke F; Schumacher M; Jonat W
J Clin Oncol; 2004 Jun; 22(12):2273-83. PubMed ID: 15111618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
